Vinorelbine is a medication used in the treatment of various types of cancer, including breast cancer, non-small cell lung cancer, and ovarian cancer. It belongs to a class of drugs known as vinca alkaloids.

Vinorelbine works by disrupting the microtubules in cancer cells, which are essential for cell division and growth. By inhibiting the formation of the mitotic spindle, it interferes with cell division and ultimately leads to the death of cancer cells.


The medication is typically administered intravenously and may be given as a single agent or in combination with other chemotherapy drugs. The specific dosage and treatment regimen depend on the type and stage of cancer being treated, as well as the overall treatment plan determined by the healthcare provider.

Common side effects of vinorelbine may include fatigue, nausea, vomiting, constipation, hair loss, and decreased white blood cell count. It can also cause infusion reactions, peripheral neuropathy, and bone marrow suppression. Regular monitoring and close communication with the healthcare team are important to manage and address any potential side effects.


Vinorelbine should only be administered under the supervision and prescription of a qualified healthcare professional experienced in cancer treatment. Adherence to the prescribed dosage and schedule is crucial for the effectiveness and safety of the treatment.

In summary, vinorelbine is a medication used in the treatment of various types of cancer. It disrupts the microtubules in cancer cells, inhibiting cell division and leading to cancer cell death. Regular monitoring and management of potential side effects are important during treatment. Vinorelbine should be administered by a healthcare professional in accordance with a comprehensive treatment plan for optimal outcomes.